Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)
Closed
Phase 3
This trial is looking at different treatments for acute myeloid leukaemia (AML).
It is for people who are fit enough to have intensive treatment.
This trial is supported by Cancer Research UK.
Please note: previous versions of the protocol included people who had a type of blood disorder called myelodysplastic syndromes (MDS). But the new version is only for people who have AML.
Recruitment start: 9 November 2015
Recruitment end: 29 October 2021
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Nigel Russell
Cancer Research UK
Cardiff University
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
This is Cancer Research UK trial number CRUK/13/35
Last reviewed: 5 November 2021
CRUK internal database number: 11756
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
